By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BioTime, Inc. 

1301 Harbor Bay Parkway

Alameda  California  94502  U.S.A.
Phone: 510-521-3390 Fax: 510-521-3389


Company News
BioTime (BTX) Announces Full Exercise And Closing Of Underwriters’ Over-Allotment Option 7/5/2016 10:52:41 AM
BioTime (BTX) Presents Online Resource For Applying Artificial Intelligence To Stem Cell Biology At Mensa 2016 Annual Gathering 6/29/2016 9:17:33 AM
BioTime (BTX) Announces Closing Of Public Offering Of Common Stock 6/21/2016 10:42:03 AM
BioTime (BTX) Announces Proposed Public Offering Of Common Stock 6/16/2016 8:35:03 AM
BioTime (BTX)’s Subsidiary Cell Cure Neurosciences Receives DSMB Approval To Start Second Patient Cohort In Clinical Trial For Dry-AMD 6/13/2016 10:44:38 AM
BioTime (BTX) Announces $2.2 Million Grant For Further Development Of Dry-AMD Program 6/10/2016 7:38:12 AM
BioTime (BTX) To Present At The Jefferies 2016 Global Healthcare Conference 6/9/2016 8:29:39 AM
BioTime (BTX) To Present At Two Upcoming Investor Conferences 5/23/2016 9:34:23 AM
BioTime (BTX) Reports First Quarter Results And Recent Corporate Accomplishments 5/11/2016 10:29:27 AM
ReCyte Therapeutics, Inc., A BioTime (BTX) Subsidiary, Announces Peer-Reviewed Publication On Pericyte-Like Progenitor Cells 5/6/2016 9:54:02 AM